Phase 2 Clinical Trial of KH617

Clinical trial NCT07138001 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07138001
Sponsor: Sichuan Honghe Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2025-08-01
Primary completion: 2027-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.